News


05/16/12, Bayer HealthCare Pharmaceuticals Bayer to Present Data on Late-Stage Development Oncology Compounds at ASCO 2012 First data from Phase III trial for regorafenib in gastrointestinal tumors (GIST) presented as Late-Breaking Abstract in Oral Abstract Session / Updated survival results from Phase III trial for Alpharadin (radium-223 chloride) in castration-resistant prostate cancer (CRPC) presented as Late-Breaking Abstract in Oral Abstract Session more

Focus on Girls – Worldwide

H.E. Kennedy Nyauncho Osinde, Kenyian Embassador, and Karin Roth Member of Parliament
Equal opportunities are a human right, yet girls are still being disadvantaged. more

24 March - World Tuberculosis Day

Tuberkulose Verbreitung
30 years after discovery of the tuberculosis bacterium, it has still not been possible to eradicate tuberculosis. more

The Labtour: From molecules to medicine

Which path does a molecule have to take to become a reliable pharmaceutical product? more

http://www.bayerpharma.com/en/index.php

Copyright © Bayer Pharma AG